Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
Clinical and Vaccine Immunology : CVI|October 24, 2014
Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c miceMaria Clausse, Alejandra G Díaz, Andrés E Ibañez, et al.Frontiers in Immunology|November 19, 2025
Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.Frontiers in Immunology|November 19, 2025
Correction: Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulationsLorena M Coria, Celeste Pueblas Castro, Laura Bruno, et al.Cellular Microbiology|October 31, 2012
Brucella abortus induces intracellular retention of MHC-I molecules in human macrophages down-modulating cytotoxic CD8(+) T cell responsesPaula Barrionuevo, M Victoria Delpino, Roberto G Pozner, et al.Clinical and Diagnostic Laboratory Immunology|March 5, 2002
Diagnostic usefulness of antibodies against ribosome recycling factor from Brucella melitensis in human or canine brucellosisJuliana Cassataro, M Victoria Delpino, Carlos A Velikovsky, et al.Microbes and Infection|April 21, 2009
Brucella abortus activates human neutrophilsAstrid Zwerdling, M Victoria Delpino, Karina A Pasquevich, et al.Veterinary Microbiology|August 26, 2004
Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovisSilvia M Estein, Pablo C Cheves, María A Fiorentino, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 30, 2018
Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrierLorena M Coria, Gabriela S Risso, Francisco F Guaimas, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 6, 2020
Sublingual Omp16-driven redirection of the allergic intestinal response in a pre-clinical model of food allergyMaria Lucía Orsini Delgado, Gastón Pascual Rizzo, Carlos Alberto Fossati, et al.Infection and Immunity|September 23, 2003
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation usedCarlos A Velikovsky, Fernando A Goldbaum, Juliana Cassataro, et al.Pageof 7